After years of escalating pressure and legislative debate, the Consolidated Appropriations Act of 2026 has finally landed, bringing with it a wave of reforms aimed at the powerful and often opaque world of Pharmacy Benefit Managers (PBMs). Employer groups, representing the health plans of more than
The Growing Imperative for a Stronger Financial Safety Net In an era of escalating healthcare costs and rising insurance deductibles, American workers are increasingly facing a daunting financial reality: even with health coverage, a single significant medical event can lead to substantial
The daily reality for a post-acute care administrator often involves navigating a deluge of fragmented patient data from hospital EMRs, faxes, and referral portals, all while a ticking clock pressures them to make a high-stakes decision on admission. This single, critical choice—whether a facility c
I'm joined today by Faisal Zain, a leading expert in U.S. healthcare policy with deep insights into hospital finance and pharmaceutical pricing. We're here to unpack the recent, and for many, welcome decision by the Department of Health and Human Services to scrap its controversial 340B
The long-standing challenge for health insurers has always been peering through the fog of information asymmetry, where a potential policyholder knows far more about their personal health risks than the underwriter ever could. This fundamental imbalance has traditionally led to generalized risk
For decades, the intricate and often bewildering system of prescription drug pricing in the United States has been orchestrated by powerful but little-understood intermediaries whose operations remained largely shielded from public and regulatory view. These entities, known as Pharmacy Benefit
